Abby Krichman

1.9k total citations · 1 hit paper
15 papers, 1.4k citations indexed

About

Abby Krichman is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Hepatology. According to data from OpenAlex, Abby Krichman has authored 15 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 8 papers in Cardiology and Cardiovascular Medicine and 3 papers in Hepatology. Recurrent topics in Abby Krichman's work include Pulmonary Hypertension Research and Treatments (13 papers), Cardiovascular Issues in Pregnancy (7 papers) and Liver Disease and Transplantation (3 papers). Abby Krichman is often cited by papers focused on Pulmonary Hypertension Research and Treatments (13 papers), Cardiovascular Issues in Pregnancy (7 papers) and Liver Disease and Transplantation (3 papers). Abby Krichman collaborates with scholars based in United States and Austria. Abby Krichman's co-authors include Michael D. McGoon, Robyn J. Barst, Gary E. Raskob, Harrison W. Farber, Theodore G. Liou, Raymond L. Benza, Adaani Frost, Dave P. Miller, David B. Badesch and Kathy Feldkircher and has published in prestigious journals such as CHEST Journal, Transplantation and Mayo Clinic Proceedings.

In The Last Decade

Abby Krichman

15 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pulmonary Arterial Hypertension

2009 866 citations David B. Badesch, Gary E. Raskob et al. CHEST Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Abby Krichman United States	7	1.3k	867	308	159	144	15	1.4k
Kathy Feldkircher United States	5	1.2k 0.9×	774 0.9×	288 0.9×	140 0.9×	102 0.7×	8	1.3k
Shelley Shapiro United States	13	1.4k 1.0×	781 0.9×	234 0.8×	109 0.7×	157 1.1×	29	1.5k
A. Yaïci France	9	1.1k 0.8×	554 0.6×	362 1.2×	102 0.6×	111 0.8×	18	1.2k
Franck‐Olivier Le Brun United States	10	1.1k 0.8×	775 0.9×	215 0.7×	133 0.8×	108 0.8×	16	1.3k
Nicola Benjamin Germany	19	1.1k 0.8×	728 0.8×	143 0.5×	93 0.6×	81 0.6×	74	1.3k
Gerrina Ruiter Netherlands	12	624 0.5×	450 0.5×	87 0.3×	51 0.3×	90 0.6×	17	794
Diane Zwicke United States	5	930 0.7×	778 0.9×	207 0.7×	145 0.9×	65 0.5×	6	1.1k
David Kylhammar Sweden	13	638 0.5×	441 0.5×	111 0.4×	73 0.5×	59 0.4×	22	710
SJ Wort United Kingdom	6	615 0.5×	355 0.4×	120 0.4×	49 0.3×	62 0.4×	31	680
Abby Poms United States	7	585 0.4×	374 0.4×	100 0.3×	44 0.3×	69 0.5×	12	610

Countries citing papers authored by Abby Krichman

Since Specialization

Citations

This map shows the geographic impact of Abby Krichman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abby Krichman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abby Krichman more than expected).

Fields of papers citing papers by Abby Krichman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abby Krichman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abby Krichman. The network helps show where Abby Krichman may publish in the future.

Co-authorship network of co-authors of Abby Krichman

This figure shows the co-authorship network connecting the top 25 collaborators of Abby Krichman. A scholar is included among the top collaborators of Abby Krichman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abby Krichman. Abby Krichman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Frost, Adaani, David B. Badesch, Robyn J. Barst, et al.. (2010). The Changing Picture of Patients With Pulmonary Arterial Hypertension in the United States. CHEST Journal. 139(1). 128–137. 250 indexed citations

2.

Benza, Raymond L., Dave P. Miller, Adaani Frost, et al.. (2010). Analysis of the Lung Allocation Score Estimation of Risk of Death in Patients With Pulmonary Arterial Hypertension Using Data From the REVEAL Registry. Transplantation. 90(3). 298–305. 53 indexed citations

3.

Barst, Robyn J., D. Dunbar Ivy, David B. Badesch, et al.. (2009). 708: REVEAL Registry: Comparison of Patients with Childhood-Onset and Adult-Onset Pulmonary Vascular Disease Associated with Congenital Heart Disease. The Journal of Heart and Lung Transplantation. 28(2). S312–S312. 2 indexed citations

4.

Badesch, David B., Gary E. Raskob, C. Gregory Elliott, et al.. (2009). Pulmonary Arterial Hypertension. CHEST Journal. 137(2). 376–387. 866 indexed citations breakdown →

5.

Barst, Robyn J., D. Dunbar Ivy, David B. Badesch, et al.. (2009). 397: REVEAL Registry: Pediatric IPAH Versus Pediatric Pulmonary Vascular Disease Associated with Congenital Heart Disease. The Journal of Heart and Lung Transplantation. 28(2). S203–S203. 1 indexed citations

6.

Barst, Robyn J., D. Dunbar Ivy, David B. Badesch, et al.. (2009). 228: REVEAL Registry: Comparison of Patients with Childhood-Onset and Adult-Onset Idiopathic Pulmonary Arterial Hypertension. The Journal of Heart and Lung Transplantation. 28(2). S146–S146. 3 indexed citations

7.

McGoon, Michael D., Abby Krichman, Harrison W. Farber, et al.. (2008). Design of the REVEAL Registry for US Patients With Pulmonary Arterial Hypertension. Mayo Clinic Proceedings. 83(8). 923–931. 102 indexed citations

8.

McGoon, Michael D., Abby Krichman, Harrison W. Farber, et al.. (2008). Design of the REVEAL Registry for US Patients With Pulmonary Arterial Hypertension. Mayo Clinic Proceedings. 83(8). 923–931. 78 indexed citations

9.

Frost, Adaani, David B. Badesch, Robyn J. Barst, et al.. (2008). A COMPARISON OF REVEAL REGISTRY DEMOGRAPHIC DATA WITH OTHER/PRIOR REGISTRIES OF PULMONARY ARTERIAL HYPERTENSION (PAH). CHEST Journal. 134(4). 134P–134P. 3 indexed citations

10.

Frost, Adaani, et al.. (2008). 317: REVEAL Registry: Does the LAS Score Underestimate the Risk of Death in IPAH. The Journal of Heart and Lung Transplantation. 27(2). S175–S175. 1 indexed citations

11.

Widlitz, Allison, et al.. (2007). Practical Aspects of Continuous Intravenous Treprostinil Therapy. Critical Care Nurse. 27(2). 41–50. 11 indexed citations

12.

Badesch, David B., et al.. (2007). REVEAL REGISTRY: BASELINE CHARACTERISTICS OF THE FIRST 1,226 ENROLLED PATIENTS. CHEST Journal. 132(4). 473B–473B. 4 indexed citations

13.

McLaughlin, Vallerie V., Robyn J. Barst, Mardi Gomberg‐Maitland, et al.. (2005). ONE YEAR EXPERIENCE WITH INTRAVENOUS TREPROSTINIL IN PULMONARY ARTERIAL HYPERTENSION (PAH) PATIENTS. CHEST Journal. 128(4). 160S–160S. 3 indexed citations

14.

Hargett, C William, Sarah A. Myers, Gregory S. Ahearn, Abby Krichman, & Victor F. Tapson. (2004). Epoprostenol-Induced Leukocytoclastic Vasculitis. CHEST Journal. 126(4). 958S–958S. 1 indexed citations

15.

Hargett, C William, et al.. (2004). Thrombocytopenia Associated with Chronic Intravenous Epoprostenol Therapy. CHEST Journal. 126(4). 760S–760S. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact